Sniper2L is a high-fidelity Cas9 variant with high activity

被引:20
|
作者
Kim, Young-hoon [1 ,2 ,3 ,4 ]
Kim, Nahye [2 ,5 ]
Okafor, Ikenna [6 ]
Choi, Sungchul [2 ]
Min, Seonwoo [7 ]
Lee, Joonsun [1 ]
Bae, Seung-Min [1 ]
Choi, Keunwoo [1 ]
Choi, Janice [8 ]
Harihar, Vinayak [8 ]
Kim, Youngho [1 ]
Kim, Jin-Soo [9 ,10 ]
Kleinstiver, Benjamin P. [11 ,12 ,13 ]
Lee, Jungjoon K. [1 ]
Ha, Taekjip [8 ,14 ,15 ,16 ]
Kim, Hyongbum Henry [2 ,4 ,5 ,17 ,18 ,19 ,20 ]
机构
[1] Toolgen, Seoul, South Korea
[2] Yonsei Univ, Dept Pharmacol, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Grad Program Biomed Engn, Coll Med, Seoul, South Korea
[4] Yonsei Univ, Grad Program Nanosci & Technol, Seoul, South Korea
[5] Yonsei Univ, Grad Sch Med Sci, Brain Korea Project 21, Coll Med, Seoul, South Korea
[6] Johns Hopkins Univ, Dept Biol, Baltimore, MD USA
[7] LG AI Res, Seoul, South Korea
[8] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA
[9] Natl Univ Singapore, Dept Biochem, Singapore, Singapore
[10] Natl Univ Singapore, NUS Synthet Biol Clin & Technol Innovat SynCTI, Singapore, Singapore
[11] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA USA
[12] Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA
[13] Harvard Med Sch, Dept Pathol, Boston, MA USA
[14] Johns Hopkins Univ, Dept Biophys & Biophys Chem, Baltimore, MD 21218 USA
[15] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA
[16] Howard Hughes Med Inst, Baltimore, MD 21250 USA
[17] Inst for Basic Sci Korea, Ctr Nanomed, Seoul, South Korea
[18] Yonsei Univ, Yonsei Inst Basic Sci Inst, Seoul, South Korea
[19] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul, South Korea
[20] Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul, South Korea
基金
美国国家卫生研究院; 新加坡国家研究基金会;
关键词
TARGET CLEAVAGE; DNA; RNA; CRISPR; SPECIFICITY; NUCLEASES; COMPLEX;
D O I
10.1038/s41589-023-01279-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although several high-fidelity SpCas9 variants have been reported, it has been observed that this increased specificity is associated with reduced on-target activity, limiting the applications of the high-fidelity variants when efficient genome editing is required. Here, we developed an improved version of Sniper-Cas9, Sniper2L, which represents an exception to this trade-off trend as it showed higher specificity with retained high activity. We evaluated Sniper2L activities at a large number of target sequences and developed DeepSniper, a deep learning model that can predict the activity of Sniper2L. We also confirmed that Sniper2L can induce highly efficient and specific editing at a large number of target sequences when it is delivered as a ribonucleoprotein complex. Mechanically, the high specificity of Sniper2L originates from its superior ability to avoid unwinding a target DNA containing even a single mismatch. We envision that Sniper2L will be useful when efficient and specific genome editing is required.
引用
收藏
页码:972 / +
页数:31
相关论文
共 50 条
  • [11] Computational normal mode analysis accurately replicates the activity and specificity profiles of CRISPR-Cas9 and high-fidelity variants
    Shor, Oded
    Rabinowitz, Roy
    Offen, Daniel
    Benninger, Felix
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 2013 - 2019
  • [12] Versatile High-Throughput Fluorescence Assay for Monitoring Cas9 Activity
    Seamon, Kyle J.
    Light, Yooli K.
    Saada, Edwin A.
    Schoeniger, Joseph S.
    Harmon, Brooke
    ANALYTICAL CHEMISTRY, 2018, 90 (11) : 6913 - 6921
  • [13] Implementing accelerated dynamics to unravel the effects of high-fidelity Cas9 mutants on target DNA and guide RNA hybrid stability
    Vora, Dhvani Sandip
    Jaiswal, Atul Kumar
    Sundar, Durai
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (13) : 6178 - 6190
  • [14] NmeCas9 is an intrinsically high-fidelity genome-editing platform
    Amrani, Nadia
    Gao, Xin D.
    Liu, Pengpeng
    Edraki, Alireza
    Mir, Aamir
    Ibraheim, Raed
    Gupta, Ankit
    Sasaki, Kanae E.
    Wu, Tong
    Donohoue, Paul D.
    Settle, Alexander H.
    Lied, Alexandra M.
    McGovern, Kyle
    Fuller, Chris K.
    Cameron, Peter
    Fazzio, Thomas G.
    Zhu, Lihua Julie
    Wolfe, Scot A.
    Sontheimer, Erik J.
    GENOME BIOLOGY, 2018, 19
  • [15] High fidelity CRISPR/Cas9 increases precise monoallelic and biallelic editing events in primordial germ cells
    Idoko-Akoh, Alewo
    Taylor, Lorna
    Sang, Helen M.
    McGrew, Michael J.
    SCIENTIFIC REPORTS, 2018, 8
  • [16] Simultaneous knockout of multiple LHCF genes using single sgRNAs and engineering of a high-fidelity Cas9 for precise genome editing in marine algae
    Sharma, Amit K.
    Nymark, Marianne
    Flo, Snorre
    Sparstad, Torfinn
    Bones, Atle M.
    Winge, Per
    PLANT BIOTECHNOLOGY JOURNAL, 2021, 19 (08) : 1658 - 1669
  • [17] High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
    Kleinstiver, Benjamin P.
    Pattanayak, Vikram
    Prew, Michelle S.
    Tsai, Shengdar Q.
    Nguyen, Nhu T.
    Zheng, Zongli
    Joung, J. Keith
    NATURE, 2016, 529 (7587) : 490 - +
  • [18] Structural insights into a high fidelity variant of SpCas9
    Guo, Minghui
    Ren, Kuan
    Zhu, Yuwei
    Tang, Ziyun
    Wang, Yuhang
    Zhang, Bailing
    Huang, Zhiwei
    CELL RESEARCH, 2019, 29 (03) : 183 - 192
  • [19] Effective gene editing by high-fidelity base editor 2 in mouse zygotes
    Liang, Puping
    Sun, Hongwei
    Ying Sun
    Zhang, Xiya
    Xie, Xiaowei
    Zhang, Jinran
    Zhen Zhang
    Chen, Yuxi
    Ding, Chenhui
    Xiong, Yuanyan
    Ma, Wenbin
    Dan Liu
    Huang, Junjiu
    Zhou Songyang
    PROTEIN & CELL, 2017, 8 (08) : 601 - 611
  • [20] A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
    Vakulskas, Christopher A.
    Dever, Daniel P.
    Rettig, Garrett R.
    Turk, Rolf
    Jacobi, Ashley M.
    Collingwood, Michael A.
    Bode, Nicole M.
    McNeill, Matthew S.
    Yan, Shuqi
    Camarena, Joab
    Lee, Ciaran M.
    Parka, So Hyun
    Wiebking, Volker
    Bak, Rasmus O.
    Gomez-Ospina, Natalia
    Pavel-Dinu, Mara
    Sun, Wenchao
    Bao, Gang
    Porteus, Matthew H.
    Behlke, Mark A.
    NATURE MEDICINE, 2018, 24 (08) : 1216 - +